Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2) Completed Phase 2 Trials for Fludarabine (DB01073)

Also known as: Myelodysplastic Syndrome With Excess Blasts-2

IndicationStatusPhase
DBCOND0092771 (Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01858740Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in ChildrenTreatment
NCT02756572Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid NeoplasmsTreatment